Generalized α-investing: Definitions, optimality results and application to public databases

Journal of the Royal Statistical Society. Series B: Statistical Methodology

Volumn 76, Issue 4, 2014, Pages 771-794

  Aharoni, Ehud ^a   Rosset, Saharon ^b  

^a IBM HAIFA RESEARCH LAB   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

False discovery rate; Familywise error rate; Multiple comparisons; investing; spending

Indexed keywords

EID: 84905914202     PISSN: 13697412     EISSN: 14679868     Source Type: Journal    
DOI: 10.1111/rssb.12048     Document Type: Article

References (18)

1. Aharoni, E., Neuvirth, H. and Rosset, S. (2011) The quality preserving database: a computational framework for encouraging collaboration, enhancing power and controlling false discovery. Computnl Biol. Bioinform., 8, 1431-1437.
2. Bao, Y., Bolotov, P., Dernovoy, D., Kiryutin, B., Zaslavsky, L., Tatusova, T., Ostell, J. and Lipman, D. (2008) The influenza virus resource at the national center for biotechnology information. J. Virol., 82, 596-601.
3. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B, 57, 289-300.
4. Benjamini, Y. and Yekutieli, D. (2001) The control of the false discovery rate in multiple testing under dependency. Ann. Statist., 29, 1165-1188.
5. Foster, D. P. and Stine, R. A. (2008) α-investing: a procedure for sequential control of expected false discoveries. J. R. Statist. Soc. B, 70, 429-444.
6. Hardy, J. and Singleton, A. (2009) Genomewide association studies and human disease. New Engl. J. Med., 360, 1759-1768.
7. Hirschhorn, J. N. and Daly, M. J. (2005) Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet., 6, 95-108.
8. Ioannidis, J. P. (2005) Why most published research findings are false. PLOS Med., 2, article e124.
9. Lander, E. and Kruglyak, L. (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet., 11, 241-247.
10. Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet., 43, 436-441.
11. Neuvirth, H., Heinemann, U., Birnbaum, D., Tishby, N. and Schreiber, G. (2007) Promateus-an open research approach to protein-binding sites analysis. Nucleic Acids Res., 35, suppl. 2, W543-W548.
12. van den Oord, E. J. C. G. and Sullivan, P. F. (2003) False discoveries and models for gene discovery. Trends Genet., 19, 537-542.
13. Rhee, S.-Y., Gonzales, M. J., Kantor, R., Betts, B. J., Ravela, J. and Shafer, R. W. (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res., 31, 298-303.
14. Simes, R. J. (1986) Publication bias: the case for an international registry of clinical trials. J. Clin. Oncol., 4, 1529-1541.
15. Storey, J. D. (2002) A direct approach to false discovery rates. J. R. Statist. Soc. B, 64, 479-498.
16. Tang, H., Peng, J., Wang, P., Coram, M. and Hsu, L. (2007) Combining multiple family-based association studies. BMC Proc., 1, suppl. 1, S162.
17. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature, 447, 661-678.
18. Wellcome Trust Case Control Consortium (2010) Genome-wide association study of CNVs in 16, 000 cases of eight common diseases and 3, 000 shared controls. Nature, 464, 713-720.